Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

A smartphone app to help manage depression symptoms

Official title: Treating Depression on a Day-to-day Basis: Development of a Novel Clinical Tool for Physicians Based on a Smartphone Application, the SMART Project (Smartphones and Mood Disorders, an Application for Research and Treatment)

Run by Centre Hospitalier Charles Perrens, Bordeaux · NCT03678194 · Data updated 2026-11-12

This study is testing a smartphone app that helps people with depression track their symptoms and treatment to see if it can improve their care.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorCentre Hospitalier Charles Perrens, Bordeaux
Government
Locations1 site (Bordeaux)
StatusRecruiting
StartedOctober 14, 2020
Main results expectedDecember 31, 2024
Study endsDecember 31, 2026
Registry record updatedMarch 16, 2026
Trial IDNCT03678194 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 65 who have recently started antidepressant treatment and meet the criteria for depression.

Probably not a fit

Patients with severe psychiatric disorders such as schizophrenia or bipolar disorder, or those unable to use the smartphone app due to cognitive or sensory impairments, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests and validates a smartphone application designed to monitor and understand daily symptoms of depression, medication adherence, and treatment effectiveness. By utilizing Ecological Momentary Assessment (EMA), the app collects real-time data from patients in their daily lives, aiming to identify factors that influence mood fluctuations and adherence to treatment. The goal is to enhance patient care by providing insights that can lead to tailored interventions based on individual patient needs.

Why it matters

Potential benefit: If successful, this approach could significantly improve the management of depression by enabling personalized treatment strategies.

How similar studies have gone: Previous studies using similar EMA approaches in psychiatry have shown promising results in understanding mood disorders and improving treatment adherence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years;
* Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview;
* Patients started their antidepressant treatment less than 5 days before inclusion;
* Patient treated in an outpatient setting;
* Patient informed of the diagnosis of his disease;
* Informed patient with written consent.

Exclusion Criteria:

* A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward;
* A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features;
* Cognitive deficit and not thus being able to comprehend the informed consent and study procedure;
* Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….);
* Non-comprehension of the French language

Where it's running

  • Centre Hospitalier Charles PERRENS
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.